Accelerate decision making through a full-suite and customised safety assessment solutions

In the drug discovery lifecycle, its critical to take early go/no go decisions which can help save immensely on both time and cost. It is also extremely important to have the drug candidates holistically evaluated for toxicity and efficacy during preclinical studies with closest resemblance to human disease conditions.

GV Safety Assessment Platform offers a wide range of GLP and Non-GLP solutions in areas of In-vitro and In-vivo toxicology in accordance with leading regulatory bodies to help you propel your drug research outcomes in the right direction.


In-vitro Toxicology

  • Cytotoxicity Assay (MTT)
  • 3T3-NRU Assay
  • HET-CAM Test

In-vivo Toxicology

  • Acute (All routes of administration)
  • Dose Range Finding (DRF) / Maximum Tolerated Dose (MTD)
  • Read More


  • Bacterial Reverse Mutation Test (AMES Test)
  • In Vitro Mammalian Chromosome Aberration Test
  • Read More

Contact Us.